Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of PharmaCyte Biotech (NASDAQ:PMCB) through any online brokerage.
Other companies in PharmaCyte Biotech’s space includes: Acurx Pharmaceuticals Inc (NASDAQ:ACXP), Can Fite Biofarma Ltd (AMEX:CANF), Genprex Inc (NASDAQ:GNPX), Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) and VivoSim Labs Inc (NASDAQ:VIVS).
There is no analysis for PharmaCyte Biotech to provide a consensus price target.
The stock price for PharmaCyte Biotech (NASDAQ: PMCB) is $0.8516 last updated December 18, 2025 at 11:21 AM EST.
There are no upcoming dividends for PharmaCyte Biotech.
PharmaCyte Biotech does not have any upcoming earnings scheduled.
There is no upcoming split for PharmaCyte Biotech.
PharmaCyte Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.